National Comprehensive Cancer Network



About NCCN

Pancreatic Adenocarcinoma Panel - Disclosures as of 8/5/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Horacio J. Asbun, MD

None

None

None

None

None

12/7/2014

Stephen Behrman, MD

None

None

None

None

None

5/4/2015

Al B. Benson III, MD, FACP, FASCO

Amgen Inc.;
Bayer HealthCare;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Advanced Accelerator Applications SA;
Alchemia;
Astellas;
Aveo;
Gilead;
Infinity

Bayer HealthCare;
Bristol-Myers Squibb Company;
Celgene Corporation;
Eli Lilly and Company;
Genentech, Inc.;
Genomic Health, Inc.;
ImClone Systems Incorporated;
Merck & Co., Inc.;
National Cancer Institute;
Spectrum Pharmaceutics;
Vicus;
Pharmacyclics;
Precision Therapeutics, Inc.;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

None

None

None

7/23/2015

Jordan D. Berlin, MD

Abbott Laboratories;
AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
ImClone Systems Incorporated;
Novartis Pharmaceuticals Corporation;
OncoMed Pharmaceuticals;
immunomedics;
merrimack;
momentum;
otsuka;
Phoenix Biotechnologies;
Taiho Parmaceuticals Co., Ltd.

Abbott Laboratories;
Bristol-Myers Squibb Company;
Celgene Corporation;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
symphogen;
targovax;
Roche Laboratories, Inc.;
Taiho Parmaceuticals Co., Ltd.;
Vertex Pharmaceuticals Incorporated

None

None

None

2/13/2015

Marian Birkeland, PhD

None

None

None

None

None

4/13/2015

Jennifer Burns

None

None

None

None

None

4/9/2015

Charles Cha, MD

None

None

None

None

None

10/8/2014

E. Gabriela Chiorean, MD

Bristol-Myers Squibb Company;
Celgene Corporation;
Genentech, Inc.;
Incyte Pharmaceuticals;
Prism Pharmaceuticals;
Spectrum Pharmaceuticals

Celgene Corporation;
Genentech, Inc.;
Merrimack Pharmaceuticals;
Pfizer Inc.

None

None

None

6/12/2015

Vincent Chung, MD

None

None

Celgene Corporation

None

None

6/12/2015

Steven J. Cohen, MD

Genentech, Inc.

Genentech, Inc.

Bristol-Myers Squibb Company;
Genentech, Inc.

None

None

10/7/2013

Brian Czito, MD

Abbott Laboratories

Pfizer Inc.

None

None

None

8/17/2014

Susan Darlow, PhD

None

Fox Chase Cancer Center

None

None

None

4/9/2015

Mary Dillhoff, MD

         

Pending

Anitra Engebretson

None

None

None

None

None

5/16/2015

Mary Feng, MD

None

None

None

None

None

5/15/2015

Fayna Ferkle, PharmD

None

None

None

None

None

4/9/2015

Cristina R. Ferrone, MD

         

Pending

Deborah Freedman-Cass, PhD

None

None

None

None

None

4/9/2015

Lauren Gallagher, RPh, PhD

None

None

None

None

None

6/8/2015

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

4/15/2015

William G. Hawkins, MD

New Link Genetics;
Olympus

None

None

None

None

4/30/2015

Joseph Herman, MD

None

Merrimack;
Oncosil

None

None

None

7/9/2015

John P. Hoffman, MD

None

None

None

None

None

6/19/2015

Andrew H. Ko, MD

Celgene Corporation;
Genentech, Inc.;
Merck & Co., Inc.;
Acerta;
Aduro Biotech;
InCyte;
Merrimack

ARMO Biosciences;
Halozyme;
Merrimack

None

None

None

4/30/2015

Srinadh Komanduri, MD

None

None

None

None

None

5/7/2015

Albert Koong, MD, PhD

None

None

None

None

None

5/8/2015

Andrew M. Lowy, MD

Halozyme Therapeutics

Merck & Co., Inc.;
;
Bexion Inc;
Pfizer Inc.

None

None

None

5/2/2015

Wen Wee Ma, MD

Bayer HealthCare;
Novartis Pharmaceuticals Corporation;
EMD Serono;
Halozyme Therapeutics;
Kinex Pharmaceuticals;
Onconova Therapeutics;
SunPharma Research

None

None

None

None

4/30/2015

Mokenge P. Malafa, MD, FACS

None

None

None

None

None

5/6/2015

Joan S. McClure, MS

None

None

None

None

None

6/18/2015

Sean J. Mulvihill, MD

National Cancer Institute;
National Cancer Institute

Myriad Genetic Laboratories, Inc.

None

None

None

6/12/2015

Eric K. Nakakura, MD

None

None

None

None

None

6/26/2014

Eileen M. O'Reilly, MD

Celgene Corporation;
Myriad Genetic Laboratories, Inc.;
OncoMed Pharmaceuticals;
Aduro;
Immunomedics;
Incyte;
Momemta;
Polaris;
sanofi-aventis U.S.

Bristol-Myers Squibb Company;
Celgene Corporation;
Array;
Gilead;
Pharmacyclics;
sanofi-aventis U.S.

None

None

None

5/1/2015

Jorge Obando, MD

None

Merck & Co., Inc.

None

None

None

10/7/2013

Donna Powell, MS, CMD, RT(T)

None

None

None

None

None

4/6/2015

Sushanth Reddy, MD

None

None

None

None

None

5/5/2015

Aaron R. Sasson, MD

Sanguine Diagnostics and Therapeutics

Celgene Corporation;
Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation

None

None

3/3/2015

Margaret A. Tempero, MD

Celgene Corporation;
Celgene Corporation

Celgene Corporation;
Genentech, Inc.;
Myriad Genetic Laboratories, Inc.;
Targovox

Genentech, Inc.;
Myriad Genetic Laboratories, Inc.

None

None

5/29/2015

Colin D. Weekes, MD, PhD

Amgen Inc.;
Bayer HealthCare;
Celgene Corporation;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
OncoMed Pharmaceuticals;
Abbvie

Celgene Corporation;
Merrimack

None

None

None

9/2/2014

Robert A. Wolff, MD

None

Clovis Oncology - Rucaparib Pancreatic Advisory Board;
Precision Medicine Research Associates (PMRA)

London Health Science Centre Surgical Grand Rounds

McGraw-Hill

None

7/17/2014

Brian M. Wolpin, MD, MPH

None

None

None

None

None

11/17/2014